NIFTY
-93.20  -0.88%
 10452.30
S&P BSE SENSEX
-286.71  -0.84%
 34010.76
Cadila Healthcare Ltd.
NSE : CADILAHC BSE : 532321 ISIN code : INE010B01027
on 16-Feb-2018
NSE
-2.8    -0.67%
Rs. 414.30
 
Days Low
Rs. 412.75
Days High
Rs. 422.45

Open Rs. 415
 
52 week Low
Rs. 373.05
52 week High
Rs.558
 
 
Bid :                 414.15 (535)
Offer :        0.00 (0)
BSE
Rs.414.15
-3.3    -0.79%
on 16-Feb-2018
BSE
-3.3    -0.79%
Rs. 414.15
 
Days Low
Rs. 413.05
Days High
Rs. 422.7

Open Rs. 419
 
52 week Low
Rs. 378.55
52 week High
Rs.560
 
 
Bid :                 414.15 (535)
Offer :        0.00 (0)
NSE
Rs.414.30
-2.8    -0.67%
 
 
Last Price (Rs.)  414.15 Value  15830411.00
Net Change (Rs.)  -3.30 Best Buy  414.15
Volume  37842 Best Sell  0.00
Prev.Close (Rs.)  417.45 Best Quantity  535
Open (Rs.)  415.00 Sell Quantity  0
High (Rs.)  422.45 52-Week High (Rs.)  558.00
Low (Rs.)  412.75 52-Week Low (Rs.)  373.05
Face Value (Rs.)  1 Market Cap.(Rs/ Mn)  423983.00
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital1024.00 1024.00 1024.00 
Share Capital1024.00 1024.00 1024.00 
Share Capital1024.00 1024.00 1024.00 
Share Capital1024.00 1024.00 1024.00 
Share Capital1024.00 1024.00 1024.00 
Currents Investments0.00 1009.00 4583.00 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
Sun Pharma Inds. 575.20 1380083 81.32 0.00 0.61
Cipla 609.95 491070 172.31 50.33 0.33
Piramal Enterprises 2628.00 473830 879.41 58.38 0.79
Lupin 824.40 372676 342.26 11.85 0.91
Dr. Reddys Lab 2212.75 367081 699.88 26.51 0.90
 
Mutual Funds Holdings
 
Quarterly Result
(Rs .in millions)Dec 2017Sep 2017Jun 2017
Net Sales15738.0017383.0010554.00
Operating Profit4672.007174.002504.00
PBDT4645.006934.002385.00
Net Profit3064.004498.00914.00
More> 
 
Company News
2/12/2018 12:00:00 AM
ONGC, Cadila Healthcare and Dredging Corporation to see some action to...
2/12/2018 12:00:00 AM
Cadila Healthcare advances on completing USFDA inspection at Moraiya f...
2/10/2018 12:00:00 AM
Cadila Healthcare completes USFDA inspection at Moraiya facility
More>
 
Ratios
   Earnings Per Share (Rs)6.46 
   Book NAV/Share(Rs)64.63 
   PAT Margin (%)20.21 
   Asset Turnover(x)0.30 
   PER(x)68.57 
   Yield(%)0.72 
   EV/Core EBITDA(x)52.51 
   M Cap / Sales14.05 
   Net Sales Growth(%)-54.06 
   PAT Growth(%)-67.51 
   Total Debt/Equity(x)0.44 
   Current Ratio(x)0.71 
   Quick Ratio(x)0.40 
   Total Debt/Mcap(x)0.06 
More>